Pathogenesis of schizophrenia negative symptoms that focuses on the glutamate receptors and cannabinoid receptor
| Project/Area Number |
24791245
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Psychiatric science
|
|---|
| Research Institution | Kurume University |
|---|
Principal Investigator |
UEMATSU Ken 久留米大学, 高次脳疾患研究所, 助教 (60441672)
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2014: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2013: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Keywords | 統合失調症 / グルタミン酸受容体 / カンナビノイド受容体 / 精神薬理学 |
|---|
| Outline of Final Research Achievements |
Based on the research implementation plan, I analyzed phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 KDa (DARPP-32) which expressed especially in post synaptic cells. I treated mouse striatal slices for cannabinoid receptor agonist stimulation. Experiments were examined by western blotting methods using phospho specific antibody of DARPP-32 threonine 34 residue (Thr 34). The result is that DARPP-32 Thr 34 increase phosphorylation level by cannabinoid receptor agonist expectedly. I completed to generate cell culture for the expression of cannabinoid receptor. However, interaction between glutamate signaling to cannnbinoid is future plan of this work.
|
Report
(4 results)
Research Products
(2 results)
